Primary Care Pulse: Recorded Live on October 26, 2021

Thank you to all who joined us live Primary Care Pulse on October 26, 2021. If you were not able to join us live, the sessions have been recorded and are available below.

Upcoming Virtual Programs
Join your clinician colleagues and expert faculty as they present the latest clinical insights and guidelines during a variety of upcoming virtual education opportunities, including Primary Care Pulse and PrimaryCareNOW. View our upcoming virtual conference schedule.

Virtual Programs


Agenda

  CME/CE Accredited Session

Non-CME/CE Session
Sponsored by Industry

Click For Session Details
Session Times Listed in ET

11:25–11:55am ET    CME/CE Accredited Session

Infectious Disease

COVID-19 Web Series Part 33: Boosters and Oral Antiviral Therapy 

Ty J. Gluckman, MD, FACC, FAHA | Charles Vega, MD, FAAFP

 

With ever-changing information on the 2019 novel coronavirus (COVID-19), it is hard to keep the facts straight! There’s new information about vaccines daily but it can be challenging to keep up. In additions there is new data on emerging treatment options. Join Drs. Charles Vega and Ty Gluckman as they team up live to discuss the most recent vaccine efficacy data, the recommendations for boosters, and the new efficacy and safety data for molnupiravir.

Ty J. Gluckman, MD, FACC, FAHA

Medical Director, Center for Cardiovascular Analytics, Research, and Data Science (CARDS), Providence Heart Institute, Providence St. Joseph Health, Portland, OR

Charles Vega, MD, FAAFP

Health Sciences Clinical Professor, UC Irvine Department of Family Medicine, Assistant Dean for Culture and Community Education, Executive Director, UC Irvine Program in Medical Education for the Latino Community, UC Irvine School of Medicine, Irvine, CA

12–1pm ET    CME/CE Accredited Session

Health Equity

Alcohol and Communities of Color  

Gregory L. Hall, MD

 

Alcohol is a complex issue in any population. When working with patients of color, the issues around alcohol have added layer of complexity related to the historical impact of alcohol on communities of color. How do you have conversations about this difficult topic with patients? In this session, Dr. Gregory Hall will review the data around alcohol use in different populations and discuss both the history of alcohol and best practices for approaching alcohol when working with patients of color.

Gregory L. Hall, MD

Associate Professor of Integrative Medical Sciences, Northeast Ohio Medical University, Rootstown, OH, Associate Professor of Internal Medicine, Northeast Ohio Medical University, Rootstown, OH, Assistant Clinical Professor in Medicine, Case Western Reserve University School of Medicine, Cleveland, OH, Director, Center for African American Health, Research, Education & Policy, Cleveland, OH

1:05–1:50pm ET    Non-CME Industry Theater

Otolaryngology

Persistent Nasal Symptoms: Could It Be Polyps?

Dareen Siri, MD, FAAAAI, FACAAI

 

Use a Case Based approach to understand the efficacy and safety of XHANCE, and review an emerging approach for the stepped-care management of Nasal Polyps.

Dareen Siri, MD, FAAAAI, FACAAI

Medical Director, Midwest Allergy Sinus Asthma SC, MASA Food Allergy Center, Sneeze Wheeze and Itch Associates, LLC, Clinical Research Center, Normal, Illinois

Sponsored by Optinose, Inc.

1:55–2:25pm ET    CME/CE Accredited Session

Pain

Nonpharmacologic and Non-opioid Pharmacologic Therapies for Acute and Chronic Pain Management 

Charles E. Argoff, MD, FABPM | Oscar A. de Leon-Casasola, MD

 

In this activity, faculty will review many options of nonpharmacologic approaches as well as non-opioid pharmacologic approaches to pain management. Published guidelines for the management of painful chronic conditions such as low back pain and osteoarthritis include recommendations for nonpharmacologic approaches as well as non-opioid pharmacologic approaches. In this activity, 2 experts review recent guideline recommendations from the American College of Physicians, the American College of Rheumatology, US Veterans Affairs and Department of Defense, and the Osteoarthritis Research Society International along with the evidence supporting these recommendations.

This activity is supported by an independent educational grant from the Opioid Analgesic REMS Program Companies. Please see https://ce.opioidanalgesicrems.com/RpcCEUI/rems/pdf/resources/List_of_RPC_Companies.pdf for a listing of REMS Program Companies. This activity is intended to be fully compliant with the Opioid Analgesic REMS education requirements issued by the U.S. Food and Drug Administration (FDA).

Charles E. Argoff, MD, FABPM

Professor of Neurology, Albany Medical College, Director, Comprehensive Pain Center, Albany Medical Center, Albany, NY

Oscar A. de Leon-Casasola, MD

Professor of Anesthesiology and Medicine, Senior Vice-Chair, The Jacobs School of Medicine and Biomedical Sciences at the University at Buffalo, Chief, Pain Medicine and Professor of Oncology, Roswell Park Cancer Institute, Buffalo, NY

Supported by Opioid Analgesic REMS Program Companies

2:30–3pm ET    Non-CME Industry Theater

Infectious Diseases

Pandemic in Practice: Impact of Viral Variance, Hyperinflammation and Vaccinations on COVID-19 Outcomes

Deepa Gotur, MD | Patrick A. Taylor, MD

 

This medical podcast will educate attendees on the drivers of COVID-19 in the community, and the factors that contribute to disease progression in the hospital. 

Dr. Deepa Gotur will discuss the role of GM-CSF in hyperinflammation in the severe COVID-19 patient. 

 

Deepa Gotur, MD

Weill Cornell Medical College, TX, GSK advisory committee, Grant recipient: Chest Foundation, Roche, Biopharma, Cyclomedica, Rigel, Novartis

Patrick A. Taylor, MD

Medical Director USMA COVID Therapeutics, GSK, President & CEO York Hospital, Maine

Sponsored by Industry Sponsor here

3–3:15pm ET    Non-CME Industry Theater

Infectious Diseases

COVID-19: What Do We Know Now?

Patrick A. Taylor, MD

 

This podcast will provide attendees an update on COVID-19. Dr. Taylor will discuss current COVID-19 activity globally; review increased transmission as a consequence of variant strains, including the delta variant; and touch briefly on vaccinations and monoclonal antibodies.  

 

Patrick A. Taylor, MD

Medical Director USMA COVID Therapeutics, GSK, President & CEO York Hospital, Maine

Sponsored by Industry Sponsor here